IGC Pharma (IGC) FCF Payout Ratio (2011 - 2012)
IGC Pharma (IGC) posted quarterly FCF Payout Ratio of 0.41 for Q4 2012, down 88.5% year-over-year from 3.58 in Q1 2012, and up 140.73% quarter-over-quarter from 1.01 in Q3 2012.
IGC Pharma (IGC) FCF Payout Ratio (2011 - 2012) Analysis & Trends
IGC Pharma (IGC) has reported FCF Payout Ratio for 2 consecutive years, with 0.41 the latest figure, recorded in Q4 2012.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.77 Bn | 130.92 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.72 Bn | 77.73 Bn | 3.93 Bn | 0.17 |
| 3 | Argenx Se | 64.93 Bn | 59.75 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.06 Bn | 52.92 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.97 Bn | 36.87 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.53 Bn | 28.22 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 27.98 Bn | 9.59 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.40 Bn | 26.24 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.33 Bn | 26.49 Bn | - | 0.07 |
| 10 | IGC Pharma | 29.89 Mn | 29.63 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2012 | 0.41 |
| Sep 30, 2012 | -1.01 |
| Jun 30, 2012 | 3.31 |
| Dec 31, 2011 | 3.58 |
| Sep 30, 2011 | 2.83 |
| Jun 30, 2011 | -25.66 |